Home LiteratureArticle Details
PMID: 8445731 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.

Journal of virology ·Vol. 67 ·No. 4 ·1993-04-00 ·Pages 2266-75

Smith AJ, Srinivasakumar N, Hammarskjöld ML, Rekosh D

Abstract

The roles of the human immunodeficiency virus precursor polyproteins Pr55gag and Pr160gag-pol in viral core assembly were studied in CMT3-COS cells. To do this, the precursors were expressed separately by using a simian virus 40 late replacement vector system described previously. Consistent with previously published data, our results show that the Pr55gag precursor, when expressed alone, was able to form particles which had an immature morphology and that particle formation required the presence of a myristate addition signal at the amino terminus of the precursor. In contrast, the Pr160gag-pol precursor was not able to form particles when expressed alone, although it still underwent proteolytic processing. Coexpression of the two precursor polyproteins from separate vectors in the same cell resulted in processing of the Pr55gag in trans by the protease embedded in Pr160gag-pol and the formation of virus-like particles containing the products of both precursors. Proteolytic processing occurred independently of the presence of a functional myristate addition signal on either precursor. On the other hand, removal of myristate from one or the other precursor had nonreciprocal effects on virus particle formation. Cells expressing Pr55gag lacking myristate and Pr160gag-pol containing it did not produce particles. Cells expressing a myristylated Pr55gag and unmyristylated Pr160gag-pol still produced virus-like particles which contained nearly normal amounts of Pr160gag-pol. The results suggest that the incorporation of Pr160gag-pol into particles is largely determined by intermolecular protein-protein interactions between the two precursor polypeptides.

MeSH Terms
Animals Blotting, Western Cells, Cultured Chlorocebus aethiops Cloning, Molecular Gene Products, gag/metabolism Gene Products, pol/metabolism HIV-1/growth & development,ultrastructure In Vitro Techniques Microscopy, Electron Morphogenesis Myristates/metabolism Protein Precursors/metabolism Transfection
Chemicals
Gene Products, gag Gene Products, pol Myristates Protein Precursors p55 gag precursor protein, Human immunodeficiency virus 1
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Smith A J
Department of Microbiology, State University of New York, Buffalo 14214.
Srinivasakumar N
Hammarskjöld M L
Rekosh D
References (40)
40 references, click to expand
  1. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.
    Science. 1986 Mar 14;231(4743):1289-91 PMID: 2418504
  2. Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells.
    J Virol. 1992 May;66(5):3230-5 PMID: 1560545
  3. Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.
    J Virol. 1986 Nov;60(2):771-5 PMID: 2430111
  4. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
    Virology. 1987 Jan;156(1):171-6 PMID: 3643678
  5. Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.
    Science. 1987 Apr 17;236(4799):305-8 PMID: 2436298
  6. A structural model for the retroviral proteases.
    Nature. 1987 Sep 24-30;329(6137):351-4 PMID: 3306411
  7. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
    J Virol. 1988 Jan;62(1):139-47 PMID: 3257102
  8. Acylation of proteins with myristic acid occurs cotranslationally.
    Science. 1987 Nov 27;238(4831):1275-8 PMID: 3685978
  9. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.
    Nature. 1988 Jan 21;331(6153):280-3 PMID: 2447506
  10. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):8903-6 PMID: 3321060
  11. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.
    J Virol. 1988 Mar;62(3):795-801 PMID: 3123712
  12. Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector.
    Proc Natl Acad Sci U S A. 1988 Jan;85(2):334-8 PMID: 2829181
  13. Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.
    AIDS Res Hum Retroviruses. 1987 Fall;3(3):253-64 PMID: 3481270
  14. An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity.
    Proc Natl Acad Sci U S A. 1988 Apr;85(8):2449-53 PMID: 3282230
  15. Active human immunodeficiency virus protease is required for viral infectivity.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90 PMID: 3290901
  16. Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus.
    J Virol. 1988 Aug;62(8):3053-8 PMID: 3292793
  17. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.
    J Virol. 1992 Aug;66(8):4874-83 PMID: 1629958
  18. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.
    J Virol. 1988 Nov;62(11):3993-4002 PMID: 3262776
  19. HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems.
    Cell. 1988 Dec 23;55(6):1159-69 PMID: 3060262
  20. Molecular genetics and structure of the human immunodeficiency virus.
    J Electron Microsc Tech. 1988 Jan;8(1):17-40 PMID: 3073195
  21. Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
    Gene. 1989 Apr 15;77(1):51-9 PMID: 2744487
  22. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5 PMID: 2788277
  23. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.
    Cell. 1989 Oct 6;59(1):103-12 PMID: 2676191
  24. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
    Proc Natl Acad Sci U S A. 1989 Nov;86(22):8964-7 PMID: 2479031
  25. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7 PMID: 2405382
  26. The molecular biology of the human immunodeficiency virus.
    Biochim Biophys Acta. 1989 Dec 27;989(3):269-80 PMID: 2695170
  27. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.
    J Virol. 1990 Apr;64(4):1690-7 PMID: 2157051
  28. Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system.
    J Virol. 1990 Jun;64(6):2653-9 PMID: 2186175
  29. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles.
    J Virol. 1990 Jun;64(6):2743-50 PMID: 1692347
  30. Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases.
    J Biol Chem. 1990 Jun 25;265(18):10492-6 PMID: 2162350
  31. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
    J Virol. 1990 Aug;64(8):3938-47 PMID: 2196384
  32. A role for the aspartyl protease from the human immunodeficiency virus type 1 (HIV-1) in the orchestration of virus assembly.
    Ann N Y Acad Sci. 1990;616:73-85 PMID: 2078037
  33. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 PMID: 2014240
  34. Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells.
    J Virol. 1991 May;65(5):2751-6 PMID: 1707986
  35. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
    Nature. 1991 Apr 18;350(6319):625-6 PMID: 2017258
  36. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.
    Proc Natl Acad Sci U S A. 1991 May 15;88(10):4528-32 PMID: 2034693
  37. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.
    J Virol. 1991 Sep;65(9):5111-7 PMID: 1870215
  38. Form, function, and use of retroviral gag proteins.
    AIDS. 1991 Jun;5(6):639-54 PMID: 1883539
  39. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.
    Virology. 1992 Jan;186(1):25-39 PMID: 1727601
  40. High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector.
    Gene. 1986;43(1-2):41-50 PMID: 3019836
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-04-00
Pages
2266-75
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC240363
Subset
IM
Grants
NIAID NIH HHS · AI-25721 · United States
NIAID NIH HHS · AI-30399 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]